[Nle4, D-Phe7 ]-α-MSH inhibits toll-like receptor (TLR)2- and TLR4-Induced microglial activation and promotes a M2-Like phenotype

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Carniglia, Lila ^a   Ramírez, Delia ^a   Durand, Daniela ^a   Saba, Julieta ^a   Caruso, Carla ^a   Lasaga, Mercedes ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN DERIVATIVE; ARGINASE 1; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ALPHA INTERMEDIN; LIPOPEPTIDE; MSH, 4-NLE-7-PHE-ALPHA-; PAM(3)CSK(4) PEPTIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; GENE EXPRESSION; INFLAMMATION; MICROGLIA; NEWBORN; NONHUMAN; PHAGOCYTOSIS; RAT; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; DRUG EFFECTS; METABOLISM;

ALPHA-MSH; ANIMALS; CELLS, CULTURED; INTERLEUKIN-10; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICROGLIA; RATS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84977472783     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158564     Document Type: Article

References (60)

1. Franco R, Fernandez-Suarez D. Alternatively activated microglia and macrophages in the central nervous system. Prog Neurobiol. 2015; 131:65-86. doi: 10.1016/j.pneurobio.2015.05.003 PMID: 26067058.
2. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004; 173(6):3916-24. Epub 2004/09/10. 173/6/3916 [pii]. PMID: 15356140.
3. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011; 30(1):16-34. Epub 2011/01/18. doi: 10.3109/08830185.2010.529976 PMID: 21235323.
4. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007; 81 (1):1-5. doi: 10.1189/jlb.0306164 PMID: 17032697.
5. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004; 279(9):7370-7. Epub 2003/12/09. doi: 10.1074/jbc.M306793200 M306793200 [pii]. PMID: 14660645.
6. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia. 2010; 58(3):253-63. doi: 10.1002/glia.20928 PMID: 19705460.
7. Gurley C, Nichols J, Liu S, Phulwani NK, Esen N, Kielian T. Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-gamma Agonists. PPAR Res. 2008; 2008:453120. Epub 2008/06/28. doi: 10.1155/2008/453120 PMID: 18584038; PubMed Central PMCID: PMC2435222.
8. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008; 132(3):344-62. doi: 10. 1016/j.cell.2008.01.020 PMID: 18267068.
9. Liou HC, Hsia CY. Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease. BioEssays: news and reviews in molecular, cellular and developmental biology. 2003; 25(8):767-80. doi: 10.1002/bies.10306 PMID: 12879447.
10. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Molecular and cellular biology. 1990; 10(4):1498-506. PMID: 2181276; PubMed Central PMCID: PMC362253.
11. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008; 180(9):5771-7. Epub 2008/04/22. 180/9/5771 [pii]. PMID: 18424693.
12. Lasaga M, Debeljuk L, Durand D, Scimonelli TN, Caruso C. Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides. 2008; 29(10):1825-35. Epub 2008/ 07/16. S0196-9781(08)00269-6 [pii] doi: 10.1016/j.peptides.2008.06.009 PMID: 18625277.
13. Giuliani D, Leone S, Mioni C, Bazzani C, Zaffe D, Botticelli AR, et al. Broad therapeutic treatment window of [Nle(4), D-Phe(7)]alpha-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils. Eur J Pharmacol. 2006; 538(1-3):48-56. Epub 2006/05/02. S0014-2999(06)00294-9 [pii] doi: 10.1016/j.ejphar.2006.03.038 PMID: 16647700.
14. Giuliani D, Ottani A, Mioni C, Bazzani C, Galantucci M, Minutoli L, et al. Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. Eur J Pharmacol. 2007; 570(1-3):57-65. Epub 2007/06/26. S0014-2999(07)00626-7 [pii] doi: 10.1016/j.ejphar.2007.05.025 PMID: 17588564.
15. Caruso C, Mohn C, Karara AL, Rettori V, Watanobe H, Schioth HB, et al. Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology. 2004; 79(5):278-86. Epub 2004/06/26. doi: 10.1159/000079321 79321 [pii]. PMID: 15218320.
16. Giuliani D, Bitto A, Galantucci M, Zaffe D, Ottani A, Irrera N, et al. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways. Neurobiol Aging. 2014; 35(3):537-47. Epub 2013/10/08. doi: 10.1016/j.neurobiolaging.2013.08. 030 S0197-4580(13)00375-8 [pii]. PMID: 24094579.
17. Gonzalez PV, Schioth HB, Lasaga M, Scimonelli TN. Memory impairment induced by IL-1beta is reversed by alpha-MSH through central melanocortin-4 receptors. Brain Behav Immun. 2009; 23 (6):817-22. Epub 2009/03/12. S0889-1591(09)00069-5 [pii] doi: 10.1016/j.bbi.2009.03.001 PMID: 19275930.
18. Gonzalez P, Machado I, Vilcaes A, Caruso C, Roth GA, Schioth H, et al. Molecular mechanisms involved in interleukin 1-beta (IL-1beta)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (alpha-MSH). Brain Behav Immun. 2013; 34:141-50. Epub 2013/08/24. doi: 10.1016/j.bbi.2013.08.007 S0889-1591(13)00418-2 [pii]. PMID: 23968970.
19. Machado I, Gonzalez PV, Vilcaes A, Carniglia L, Schioth HB, Lasaga M, et al. Interleukin-1betainduced memory reconsolidation impairment is mediated by a reduction in glutamate release and zif268 expression and alpha-melanocyte-stimulating hormone prevented these effects. Brain Behav Immun. 2015; 46:137-46. doi: 10.1016/j.bbi.2015.01.012 PMID: 25637483.
20. Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, Galimberti D, et al. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol. 1998; 63 (6):740-5. Epub 1998/06/10. PMID: 9620667.
21. Carniglia L, Durand D, Caruso C, Lasaga M. Effect of NDP-alpha-MSH on PPAR-gamma and -beta expression and anti-inflammatory cytokine release in rat astrocytes and microglia. PLoS One. 2013; 8 (2):e57313. Epub 2013/03/08. doi: 10.1371/journal.pone.0057313 PONE-D-12-28242 [pii]. PMID: 23468969; PubMed Central PMCID: PMC3582497.
22. Caruso C, Carniglia L, Durand D, Gonzalez PV, Scimonelli TN, Lasaga M. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway. Mol Cell Endocrinol. 2012; 348(1):47-54. Epub 2011/08/02. S0303-7207(11) 00435-7 [pii] doi: 10.1016/j.mce.2011.07.036 PMID: 21803120.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8. Epub 2002/02/16. doi: 10.1006/ meth.2001.1262 S1046-2023(01)91262-9 [pii]. PMID: 11846609.
24. Karlstetter M, Nothdurfter C, Aslanidis A, Moeller K, Horn F, Scholz R, et al. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis. J Neuroinflammation. 2014; 11:3. Epub 2014/01/09. doi: 10.1186/1742-2094-11-3 1742-2094-11-3 [pii]. PMID: 24397957; PubMed Central PMCID: PMC3895821.
25. Bianchi ME. HMGB1 loves company. J Leukoc Biol. 2009; 86(3):573-6. Epub 2009/05/06. doi: 10. 1189/jlb.1008585 jlb.1008585 [pii]. PMID: 19414536.
26. Ribes S, Ebert S, Regen T, Agarwal A, Tauber SC, Czesnik D, et al. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun. 2010; 78(2):865-71. Epub 2009/11/26. doi: 10.1128/ IAI.01110-09 IAI.01110-09 [pii]. PMID: 19933834; PubMed Central PMCID: PMC2812218.
27. Redlich S, Ribes S, Schutze S, Eiffert H, Nau R. Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells. J Neuroinflammation. 2013; 10:71. Epub 2013/06/07. doi: 10.1186/1742-2094-10-71 1742-2094-10-71 [pii]. PMID: 23738865; PubMed Central PMCID: PMC3693974.
28. Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2013; 39(1):3-18. Epub 2012/12/21. doi: 10.1111/nan. 12011 PMID: 23252647.
29. Chhor V, Le Charpentier T, Lebon S, Ore MV, Celador IL, Josserand J, et al. Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun. 2013; 32:70-85. Epub 2013/03/05. doi: 10.1016/j.bbi.2013.02.005 S0889-1591(13)00127-X [pii]. PMID: 23454862; PubMed Central PMCID: PMC3694309.
30. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 2009; 4(4):399-418. Epub 2009/08/06. doi: 10.1007/s11481-009-9164-4 PMID: 19655259; PubMed Central PMCID: PMC2773116.
31. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in immunology. 2002; 23(11):549-55. PMID: 12401408.
32. Kawanaka N, Taylor AW. Localized retinal neuropeptide regulation of macrophage and microglial cell functionality. J Neuroimmunol. 2011; 232(1-2):17-25. doi: 10.1016/j.jneuroim.2010.09.025 PMID: 20965575; PubMed Central PMCID: PMC3030990.
33. Morris SM Jr. Arginine metabolism: boundaries of our knowledge. The Journal of nutrition. 2007; 137(6 Suppl 2):1602S-9S. PMID: 17513435.
34. Yao L, Kan EM, Lu J, Hao A, Dheen ST, Kaur C, et al. Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. J Neuroinflammation. 2013; 10:23. doi: 10.1186/1742-2094-10-23 PMID: 23388509; PubMed Central PMCID: PMC3575244.
35. Zhou H, Lapointe BM, Clark SR, Zbytnuik L, Kubes P. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J Immunol. 2006; 177(11):8103-10. PMID: 17114485.
36. Tian S, Zhang L, Tang J, Guo X, Dong K, Chen SY. HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the earlystage of obstructive injury. American journal of physiology Renal physiology. 2015; 308(1):F69-75. doi: 10.1152/ajprenal.00484.2014 PMID: 25377911; PubMed Central PMCID: PMC4281691.
37. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007; 13(11):460-9. Epub 2007/11/22. S1471-4914(07)00184-0 [pii] doi: 10.1016/j.molmed.2007.09.002 PMID: 18029230.
38. Manna SK, Aggarwal BB. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol. 1998; 161(6):2873-80. Epub 1998/09/22. PMID: 9743348.
39. Sarkar A, Sreenivasan Y, Manna SK. alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages. FEBS Lett. 2003; 553 (3):286-94. Epub 2003/10/24. S0014579303010299 [pii]. PMID: 14572638.
40. Hilliard BA, Mason N, Xu L, Sun J, Lamhamedi-Cherradi SE, Liou HC, et al. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. The Journal of clinical investigation. 2002; 110(6):843-50. doi: 10.1172/JCI15254 PMID: 12235116; PubMed Central PMCID: PMC151124.
41. Sanjabi S, Hoffmann A, Liou HC, Baltimore D, Smale ST. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc Natl Acad Sci U S A. 2000; 97(23):12705-10. doi: 10.1073/ pnas.230436397 PMID: 11058167; PubMed Central PMCID: PMC18828.
42. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine & growth factor reviews. 2003; 14(5):361-8. PMID: 12948519.
43. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. The Journal of clinical investigation. 2006; 116(5):1218-22. doi: 10.1172/JCI28508 PMID: 16670765; PubMed Central PMCID: PMC1451213.
44. Taylor AW, Kitaichi N. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy. Brain Behav Immun. 2008; 22 (5):639-46. Epub 2008/01/04. S0889-1591(07)00274-7 [pii] doi: 10.1016/j.bbi.2007.11.001 PMID: 18171609; PubMed Central PMCID: PMC3337335.
45. Heyen JR, Ye S, Finck BN, Johnson RW. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain research Molecular brain research. 2000; 77(1):138-47. PMID: 10814840.
46. Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA, Taylor PR, et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol. 2008; 38(2):500-6. doi: 10.1002/eji.200737741 PMID: 18200499; PubMed Central PMCID: PMC2430329.
47. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. The Journal of experimental medicine. 1991; 174(5):1209-20. PMID: 1940799; PubMed Central PMCID: PMC2119001.
48. Matsui T, Tasaki M, Yoshioka T, Motoki Y, Tsuneoka H, Nojima J. Temperature- and time-dependent changes in TLR2-activated microglial NF-kappaB activity and concentrations of inflammatory and antiinflammatory factors. Intensive care medicine. 2012; 38(8):1392-9. doi: 10.1007/s00134-012-2591-3 PMID: 22653369.
49. Funderburg NT, Jadlowsky JK, Lederman MM, Feng Z, Weinberg A, Sieg SF. The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human beta-defensin-3 differentially induce interleukin-10 and nuclear factor-kappaB signalling patterns in human monocytes. Immunology. 2011; 134(2):151-60. doi: 10. 1111/j.1365-2567.2011.03475.x PMID: 21896010; PubMed Central PMCID: PMC3194223.
50. Cao S, Zhang X, Edwards JP, Mosser DM. NF-kappaB1 (p50) homodimers differentially regulate proand anti-inflammatory cytokines in macrophages. J Biol Chem. 2006; 281(36):26041-50. doi: 10.1074/ jbc.M602222200 PMID: 16835236; PubMed Central PMCID: PMC2642587.
51. Clarke CJ, Hales A, Hunt A, Foxwell BM. IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur J Immunol. 1998; 28(5):1719-26. PMID: 9603479.
52. Yao J, Mackman N, Edgington TS, Fan ST. Lipopolysaccharide induction of the tumor necrosis factoralpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem. 1997; 272(28):17795-801. PMID: 9211933.
53. Udalova IA, Knight JC, Vidal V, Nedospasov SA, Kwiatkowski D. Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J Biol Chem. 1998; 273 (33):21178-86. PMID: 9694874.
54. Ponomarev ED, Maresz K, Tan Y, Dittel BN. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci. 2007; 27(40):10714-21. doi: 10.1523/JNEUROSCI.1922-07.2007 PMID: 17913905.
55. Suzumura A, Sawada M, Itoh Y, Marunouchi T. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J Neuroimmunol. 1994; 53(2):209-18. Epub 1994/09/01. PMID: 8071435.
56. Pisetsky DS, Erlandsson-Harris H, Andersson U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther. 2008; 10(3):209. Epub 2008/ 07/05. ar2440 [pii] doi: 10.1186/ar2440 PMID: 18598385; PubMed Central PMCID: PMC2483460.
57. Campana L, Bosurgi L, Rovere-Querini P. HMGB1: a two-headed signal regulating tumor progression and immunity. Curr Opin Immunol. 2008; 20(5):518-23. Epub 2008/07/05. S0952-7915(08)00054-X [pii] doi: 10.1016/j.coi.2008.04.012 PMID: 18599281.
58. Napoli I, Neumann H. Microglial clearance function in health and disease. Neuroscience. 2009; 158 (3):1030-8. doi: 10.1016/j.neuroscience.2008.06.046 PMID: 18644426.
59. Neher JJ, Neniskyte U, Zhao JW, Bal-Price A, Tolkovsky AM, Brown GC. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J Immunol. 2011; 186(8):4973-83. Epub 2011/03/16. doi: 10.4049/jimmunol.1003600 jimmunol.1003600 [pii]. PMID: 21402900.
60. Neher JJ, Emmrich JV, Fricker M, Mander PK, Thery C, Brown GC. Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc Natl Acad Sci U S A. 2013; 110(43):E4098-107. doi: 10.1073/pnas.1308679110 PMID: 24101459; PubMed Central PMCID: PMC3808587.